- Home
- JAZZ vs CX Comparison
JAZZ vs CX Comparison
Compare JAZZ & CX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAZZ
- CX
- Stock Information
- Founded
- JAZZ 2003
- CX 1906
- Country
- JAZZ Ireland
- CX Mexico
- Employees
- JAZZ N/A
- CX N/A
- Industry
- JAZZ Biotechnology: Pharmaceutical Preparations
- CX Building Materials
- Sector
- JAZZ Health Care
- CX Industrials
- Exchange
- JAZZ Nasdaq
- CX Nasdaq
- Market Cap
- JAZZ 8.4B
- CX 8.5B
- IPO Year
- JAZZ 2007
- CX 1999
- Fundamental
- Price
- JAZZ $122.92
- CX $5.66
- Analyst Decision
- JAZZ Strong Buy
- CX Buy
- Analyst Count
- JAZZ 13
- CX 6
- Target Price
- JAZZ $187.15
- CX $7.70
- AVG Volume (30 Days)
- JAZZ 1.3M
- CX 11.6M
- Earning Date
- JAZZ 04-30-2025
- CX 04-28-2025
- Dividend Yield
- JAZZ N/A
- CX 1.46%
- EPS Growth
- JAZZ 41.75
- CX 417.83
- EPS
- JAZZ 8.65
- CX 0.06
- Revenue
- JAZZ $4,068,950,000.00
- CX $16,200,000,000.00
- Revenue This Year
- JAZZ $7.30
- CX $7.56
- Revenue Next Year
- JAZZ $4.01
- CX $5.63
- P/E Ratio
- JAZZ $14.21
- CX $9.32
- Revenue Growth
- JAZZ 6.12
- CX N/A
- 52 Week Low
- JAZZ $99.06
- CX $5.00
- 52 Week High
- JAZZ $148.06
- CX $9.27
- Technical
- Relative Strength Index (RSI)
- JAZZ 32.69
- CX 38.46
- Support Level
- JAZZ $137.74
- CX $5.89
- Resistance Level
- JAZZ $142.64
- CX $6.33
- Average True Range (ATR)
- JAZZ 3.87
- CX 0.19
- MACD
- JAZZ -2.12
- CX -0.02
- Stochastic Oscillator
- JAZZ 0.45
- CX 1.47
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.
About CX Cemex S.A.B. de C.V. Sponsored ADR
Cemex SAB de CV is a ready-mix concrete company that mainly engaged in activities that are oriented to the construction industry, mainly through the production, marketing, sale, and distribution of cement, ready-mix concrete, aggregates, urbanization solutions, and other construction materials and services.